GENEVA, June 24 -- AMGEN INC. filed a patent application (US2025/057259) for “TITRATION DOSES OF MARIDEBART CAFRAGLUTIDE”. With publication no. WO/2026/117667, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....